Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 01, 2012
Local and state government officials joined representatives from Eli Lilly and Company today to announce a $140 million expansion to the company's Indianapolis insulin manufacturing operations. The 80,000-square-foot expansion, which will enable the...
read more
Tuesday, November 24, 2020
Samsung Biologics' partnership with Eli Lilly and Company is expected to accelerate the global supply for Lilly's COVID-19 antibody therapies through a long-term manufacturing agreement.
read more
Wednesday, December 30, 2020
Lipidor announced the Company has signed a new cooperation agreement with Aurena Laboratories AB.
read more
Tuesday, February 16, 2021
LipoMedix announced its lead compound, Promitil (PL-MLP), will be manufactured in the United States by ForDoz Pharma.
read more
Liveyon has voluntarily recalled all ReGen Series products due to reported possible adverse reactions.
read more
Tuesday, January 04, 2022
Lokavant, a clinical trial intelligence company, has announced an expansion of its global customer base and additions to its leadership team.
read more
Longhorn Vaccines & Diagnostics and Pharmco have combined to rapidly accelerate coronavirus testing and detection which are critical to combating the global COVID-19 pandemic.
read more
ALSA Ventures, a London based European biotech investment firm, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, announced a framework collaboration agreement to help ALSA’s portfolio of pre-...
read more
Tuesday, November 30, 2021
Bioqube Ventures, a European venture capital firm with a dual investment model including venture creation, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, today announced a framework ...
read more
BioWa, Inc. and Lonza today announced that they have entered into research agreements with Pfizer Inc. allowing the use of the POTELLIGENT® CHOK1SV Cell Line in the research and development of multiple proprietary antibodies in Pfizer’s pipeline.
read more
Thursday, September 08, 2022
Lonza agrees to cooperate with Touchlight to aid in genetic medicine advancement. Through this collaboration, Lonza will have the ability to integrate an additional,
read more
ValenzaBio, a biopharmaceutical company developing monoclonal antibody therapeutics for autoimmune and inflammatory indications, and Lonza announced that the companies have a manufacturing agreement in place.
read more
Monday, February 03, 2020
Lonza announced a clinical manufacturing agreement with Rocket Pharmaceuticals, a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders.
read more
Lonza announced it has completed the acquisition of Capsugel from KKR for $5.5 billion in cash, including refinancing of existing Capsugel debt of approximately $2 billion.
read more
Lonza has enhanced its offering for customers in the early phases of their clinical trials by adding a dedicated Early Phase Clinical Manufacturing facility at its Small Molecules site in Bend, Oregon.
read more